|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 57.18 USD | -2.16% |
|
-5.11% | -3.79% |
| Market Cap | 11.07B 9.84B 9.17B 8.36B 15.77B 1,066B 15.92B 111B 43.08B 544B 41.55B 40.65B 1,747B | P/E 2026 * |
20.8x | P/E 2027 * | 12.6x |
|---|---|---|---|---|---|
| Enterprise Value | 13.14B 11.68B 10.89B 9.92B 18.72B 1,265B 18.9B 132B 51.14B 645B 49.33B 48.26B 2,074B | EV / Sales 2026 * |
3.36x | EV / Sales 2027 * | 2.75x |
| Free-Float |
99.66% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BMRN | Delayed | |
CBOE
| BMRN | Real-time | |
|
Wiener Boerse
| BMRN | End-of-day quote | |
|
Tradegate
| BM8 | Real-time | |
|
London S.E.
| 0HNC | Delayed | |
|
Boerse Muenchen
| BM8 | Real-time | |
|
Mexican S.E.
| BMRN * | End-of-day quote | |
|
Berne S.E.
| BM8 | End-of-day quote | |
|
Deutsche Boerse AG
| BM8 | Delayed | |
|
Börse Stuttgart
| BM8 | Delayed | |
|
Borsa Italiana
| 1BMRN | End-of-day quote |
Last Transcript: BioMarin Pharmaceutical Inc.
| 1 day | -2.16% | ||
| 1 week | -5.11% | ||
| Current month | -4.70% | ||
| 1 month | -13.92% | ||
| 3 months | -3.07% | ||
| 6 months | +3.03% | ||
| Current year | -3.79% |
| 1 week | 57.15 |  | 60.7 |
| 1 month | 57.15 | | 66.88 |
| Current year | 49.26 | | 70.98 |
| 1 year | 49.26 | | 70.98 |
| 3 years | 49.26 | | 99.56 |
| 5 years | 49.26 | | 117.77 |
| 10 years | 49.26 | | 131.94 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alexander Hardy
CEO | Chief Executive Officer | 57 | 2023-11-30 |
Brian Mueller
DFI | Director of Finance/CFO | 52 | 2020-01-28 |
Arpit Davé
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-11 |
| Director | Title | Age | Since |
|---|---|---|---|
Willard Dere
BRD | Director/Board Member | 72 | 2016-07-17 |
Robert Hombach
BRD | Director/Board Member | 60 | 2017-09-28 |
| Director/Board Member | 69 | 2019-07-09 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/30/26 | Tax | Chief Technology Officer | -4,086 | 0.0021% | ||
| 9/10/26 | Free | Director | 6,140 | 0.0032% | ||
| 9/2/26 | Sell | General Counsel | -17,557 | 0.0091% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -5.11% | +3.16% | -33.66% | 11.07B | |
| -0.61% | -3.43% | +36.07% | +117.61% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.82% | 617B | |
| +1.11% | -0.58% | +12.36% | +78.27% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.79% | 356B | |
| -0.95% | -4.05% | +21.60% | +39.37% | 333B | |
| -1.46% | -2.89% | +11.84% | +24.60% | 267B | |
| -1.35% | -5.43% | -4.69% | +8.40% | 244B | |
| -1.04% | -2.79% | +35.30% | +54.42% | 218B | |
| -1.87% | -4.10% | +28.44% | +97.54% | 179B | |
| Average | -0.90% | -3.56% | +24.16% | +49.32% | 370.83B | |
| Weighted average by Cap. | -0.60% | -3.33% | +29.28% | +70.59% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.91B 3.47B 3.24B 2.95B 5.57B 376B 5.62B 39.24B 15.21B 192B 14.67B 14.35B 617B | 4.47B 3.97B 3.7B 3.37B 6.37B 430B 6.43B 44.88B 17.39B 219B 16.78B 16.41B 705B |
| Net income | 534M 475M 442M 403M 761M 51.43B 768M 5.36B 2.08B 26.22B 2B 1.96B 84.28B | 900M 800M 746M 680M 1.28B 86.71B 1.29B 9.04B 3.5B 44.22B 3.38B 3.31B 142B |
| Net Debt | 2.07B 1.84B 1.72B 1.56B 2.95B 199B 2.98B 20.8B 8.06B 102B 7.78B 7.61B 327B | 1.22B 1.08B 1.01B 921M 1.74B 117B 1.75B 12.25B 4.75B 59.9B 4.58B 4.48B 193B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-02 | US$57.18 | -2.16% | 2,192,505 |
| 26-10-01 | US$58.44 | -2.60% | 2,083,189 |
| 26-09-30 | US$60.00 | +0.22% | 1,797,910 |
| 26-09-29 | US$59.87 | +0.69% | 1,807,502 |
| 26-09-28 | US$59.46 | -1.33% | 2,357,963 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BMRN Stock
Select your edition
All financial news and data tailored to specific country editions
